Fecal microbiota transplantation may restore beneficial gut bacteria in cancer patients
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation and restoring their digestive, immune and other essential functions. The study is published Sept. 26, 2018 in Science Translational Medicine.
To continue reading this article
Continue reading your article with a eMediNexus account.